What Really Disappears When You Lose Weight on GLP-1 Drugs?
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"What Really Disappears When You Lose Weight on GLP-1 Drugs?" is generating significant coverage in the Health category, with 11 articles from 10 distinct sources tracked by PULSE so far.
Outlets currently covering the story include WOWT, CBS News, Live 5 News and NewsNation. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 60d ago.
Quick answers
Why is "What Really Disappears When You Lose Weight on GLP-1 Drugs?" trending?
Because 10 independent news sources published 11 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (11)
- Aging Untold: What you need to know before starting GLP-1 weight-loss drugs WOWT · 63d ago
- What most people get wrong about GLP-1s CBS News · 63d ago
- Aging Untold: What you need to know before starting GLP-1 weight-loss drugs Live 5 News · 63d ago
- ‘Are they okay?’: Hollywood’s too-thin problem and the $300K fix NewsNation · 63d ago
- GLP-1s, GLP-2s and “GLP-3s”: What To Know And Which Actually Support Weight Loss Forbes · 63d ago
- Want to start GLP-1 medications? Gastroenterologist Dr Saurabh Sethi shares 5 things to know beforehand Hindustan Times · 63d ago
- ‘Are they okay?’: Hollywood’s too-thin problem and the $300K fix NewsNation · 63d ago
- Can Obesity Treatment With GLP-1 Drugs Last Forever? Medscape · 63d ago
- Doctors sound the alarm over weight-loss drug ‘microdosing’ trend sweeping social media 7NEWS · 63d ago
- ‘Are they okay?’: Hollywood’s too-thin problem and the $300K fix Yahoo · 63d ago
- Are GLP-1s the New Statins? Men's Health · 63d ago
Topics
Related trends
Nvidia's first post-Jensen earnings and Anthropic's IPO: What to watch this week
Nvidia reports earnings Tuesday and Anthropic lists Thursday as tech stocks slide on leadership crisis and AI bubble fears.
What they're saying after Michigan's loss to MSU: Kyle Whittingham, staff 'in over their heads'
Michigan State's rivalry victory over Michigan triggers intense scrutiny of Kyle Whittingham's tenure as Wolverines head coach across 14 articles from eight outlets.
“What Are We Doing Here?”: Blazers Announcers Call Out Victor Wembanyama for Abusing NBA Loophole
Portland announcers sharply criticized Victor Wembanyama for utilizing an NBA rule loophole during a lopsided loss to the Spurs.
Medicare Advantage vs. Traditional Medicare: What You Need to Know
Choosing between Medicare Advantage and Original Medicare involves critical trade-offs in costs, benefits, and provider networks.
Congress Just Flipped. Here’s What Warren Buffett Does After Every Election.
Congress has flipped control after the 2026 midterms, triggering a wave of investor-focused coverage highlighting Warren Buffett's post-election strategy.
When Nvidia Stumbled, Equal-Weight Funds Delivered
Coverage from A Wealth of Common Sense examines how equal-weight funds performed after Nvidia's stumble, raising questions about concentration risk in market-cap-weighted indexes.